Southwest Research Institute
Southwest Research Institute (SwRI) is a prominent nonprofit research and development organization headquartered in San Antonio, Texas, specializing in advanced scientific and engineering services across multiple domains. The institute provides a wide range of technical solutions to federal government agencies, including comprehensive research, development, testing, and engineering services in areas such as aerospace, defense, energy, transportation, and scientific exploration. With over 2,700 staff members, SwRI is known for its multidisciplinary capabilities, focusing on creating and transferring technology in engineering and physical sciences through innovative research and technical problem-solving for government and industry clients.
Through federal contract awards, SwRI has demonstrated extensive capabilities in providing specialized technical services across numerous domains. The organization has secured contracts with agencies like NASA, the Department of Defense, the Nuclear Regulatory Commission, and the Department of Transportation, performing work such as radiochemical sample analysis, aircraft structural integrity programs, automated coating removal system maintenance, engineering support for defense systems, and development of safety-critical transportation technologies. These contracts have ranged from firm-fixed-price delivery orders to cost-plus-fixed-fee arrangements, covering activities like system repairs, technical evaluations, prototype testing, and advanced technological research. None of the contract awards examined were set aside for specific business categories, indicating SwRI's ability to compete effectively in full and open competitions.
SwRI's federal grant awards primarily focus on scientific research and technological development, particularly in space science, planetary exploration, and emerging scientific domains. The organization has received numerous grants from NASA's Science Mission Directorate, supporting research initiatives such as investigating Mars' geological features, studying solar corona dynamics, developing advanced sensor technologies, and exploring planetary habitability. These grants have covered diverse areas including heliophysics, planetary science, atmospheric modeling, and technological innovation. The grants support fundamental scientific research aimed at expanding human knowledge, with projects ranging from examining solar magnetic fields to analyzing potential microhabitable environments on ocean world ice shells.
Southwest Research Institute holds several significant federal contract Indefinite Delivery Vehicles (IDVs) that enable efficient task order procurement across government agencies. These include the One Acquisition Solution for Integrated Services Plus (OASIS+) Unrestricted Multiple Award Contract with a massive $999,999,999,999 ceiling, a Testing and Rapid Prototyping for Interoperable Automation Safety (TRPIAS) IDIQ for transportation safety technologies, and a single-award IDC with the Air Force Life Cycle Management Center supporting engineering and research activities related to system and material degradation. These IDVs span multiple agencies including the General Services Administration, Department of Transportation, and Department of Defense, allowing SwRI to provide a comprehensive range of professional services including engineering support, technology development, testing, and advanced research across civilian and defense sectors.
PB11V1KH3KV4 541330
Not listed 6220 Culebra Rd, San Antonio, TX 78238, USA
2/26/02 10/16/26 Regents Of The University Of Minnesota
The Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, is a prominent 1862 land-grant research institution that provides extensive scientific research, technical services, and educational support to multiple federal agencies. As a non-profit educational institution, the university leverages its academic expertise to execute complex research projects, develop innovative technologies, and support national priorities across diverse scientific domains including medical research, technological development, and specialized scientific services. The university is registered in SAM.gov and has demonstrated capabilities in receiving both federal contract and grant awards across numerous disciplines.
The university's federal contract work spans a wide range of specialized services and research support. Contract awards have included MRI support services for the Veterans Integrated Service Network 23, metabolomic and proteomics services, geospatial artificial intelligence projects for NOAA involving satellite imagery processing, and general chemistry lab testing for the Centers for Disease Control and Prevention. These contracts are predominantly non-set-aside and involve delivery orders and purchase orders across civilian agencies. The university has worked with agencies like the Agency for Healthcare Research and Quality, Centers for Medicare and Medicaid Services, and National Oceanic and Atmospheric Administration, demonstrating its versatility in providing technical and scientific contract services.
The federal grant awards showcase the university's deep research capabilities across multiple scientific domains. Grants have supported groundbreaking research in areas such as neuroscience, genetics, immunology, aging, cancer research, and medical technology development. Notable grant projects include investigations into brain development, cellular mechanisms of diseases, vaccine development, and advanced technological research. These awards have been funded by prestigious agencies like the National Institutes of Health, National Science Foundation, Department of Defense, and Department of Agriculture. The grants cover a broad spectrum of research activities, from basic scientific exploration to applied research with potential clinical and technological applications.
The university holds an Indefinite Delivery Contract (IDC) with the Veterans Integrated Service Network 23, which provides a framework for executing specialized research and support services. This single-award IDC has a substantial ceiling value and allows for task orders across various medical and scientific domains. The contract enables the university to provide targeted services such as MRI support, metabolomic analyses, and other specialized research support. The IDC demonstrates the university's ability to serve federal agencies through a flexible, adaptable contracting mechanism that can accommodate diverse research and technical service needs across different scientific disciplines.
KABJZBBJ4B54 611310
Not listed University Office Plaza, 2221 University Ave SE #100, Minneapolis, MN 55414, USA
2/22/02 2/26/26 Bachem Americas Inc.
Bachem Americas Inc., located in Torrance, California, is a foreign-owned, for-profit corporate entity registered in SAM.gov since 2003, specializing in pharmaceutical manufacturing and related services. The company provides critical Chemistry, Manufacturing, and Controls (CMC) services to federal agencies, with a focus on producing pharmaceutical ingredients and conducting specialized research studies. As a pharmaceutical manufacturer, Bachem Americas Inc. develops and manufactures complex drug substances for scientific and medical research purposes.
The company has been awarded multiple federal contract task orders primarily from the National Institute on Drug Abuse (NIDA) and the National Center for Advancing Translational Sciences (NCATS), focusing on stability studies and manufacturing of specific drug substances. Recent contract awards include extended stability studies for pharmaceutical compounds such as leucine enkephalin (L-ENK) and parathyroid hormone-related protein (PTH-IA), with contract values ranging from $26,400 to $597,350. These task orders involve precise scientific work like manufacturing cGMP (current Good Manufacturing Practice) batches of research compounds, conducting multi-year stability studies, and supporting drug development programs. None of the awarded contracts have been set aside, and Bachem Americas Inc. has consistently served as the prime contractor without major subcontractors.
Bachem Americas Inc. holds a significant Indefinite Delivery/Indefinite Quantity (IDIQ) contract with NCATS valued at $49,713,679, which runs through May 2031. This master IDIQ contract covers Chemistry, Manufacturing, and Controls services to support drug development programs, with a scope that includes process development, formulation studies, and cGMP manufacturing of active pharmaceutical ingredients. The contract allows for multiple task orders and was awarded with a Determination of Exceptional Circumstances regarding intellectual property rights. The IDIQ provides a framework for Bachem to continue delivering specialized scientific services to the National Institutes of Health, supporting preclinical research and pharmaceutical development across various compounds and research initiatives.
ULM6JMNK5L83 325411
Not listed 3132 Kashiwa St, Torrance, CA 90505, USA
5/15/03 10/27/26 Advanced Bioscience Laboratories, Inc.
Advanced Bioscience Laboratories, Inc. (ABL), doing business as Advanced Bioscience Laboratories Inc., is a leading contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. As a foreign-owned, for-profit manufacturer of goods, ABL provides a wide range of preclinical and clinical development services to support infectious disease research and product development initiatives for government agencies, academic institutions, and industry clients. The company's expertise spans biologics manufacturing, testing, storage, shipping, and quality assurance services. ABL has been awarded numerous federal contracts and grants, particularly from the National Institutes of Health (NIH) and Department of Health and Human Services (HHS), to advance the development of medical countermeasures for various infectious diseases and other health conditions.
Through its federal contract awards, ABL has provided a diverse array of goods and services to support preclinical and clinical development programs. These include cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management for infectious disease countermeasures such as HIV, influenza, and other vaccines and therapeutics. ABL has performed work for multiple NIH institutes, including the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), and National Institute of Neurological Disorders and Stroke (NINDS). The company has contributed to various programs, including HIV microbicides and biomedical prevention, pediatric drug formulation development, and cancer prevention initiatives. Notable projects include the manufacture of glycopeptide immunogen nanoparticle vaccines, development of bitter taste receptor blockers for pediatric medicines, and production of vaccines targeting frame-shift mutations in tumors. ABL's contracts typically do not have set-aside designations, reflecting its status as a large business in the federal contracting landscape.
ABL's involvement in federal grant programs has primarily been as a subcontractor to academic institutions. The company has supported grants focused on vaccine development and immunology studies. For instance, ABL has worked on a project to develop MecVax, a cross-protective subunit vaccine for enterotoxigenic E. coli (ETEC), in collaboration with the University of Illinois. Another significant grant-funded project involved toxicology studies and assay verification for a gonococcal peptide vaccine (TMCP2) in partnership with the University of Massachusetts Medical School. In these projects, ABL's role typically includes conducting toxicology studies, verifying immunological assays such as ELISAs and bactericidal assays, and providing technical expertise in vaccine development and testing.
ABL holds several Indefinite Delivery Vehicles (IDVs) with federal agencies, demonstrating its broad capabilities in biopharmaceutical research and development. A notable IDV is with NIAID for the Diagnostics Pre-Clinical Services Program, valued at $24 million, which supports in vitro diagnostic development. Another significant IDV is with NINDS for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders, with a ceiling of $149.2 million. ABL also holds an IDV with NIAID for Resources to Advance Pediatrics and HIV Prevention Science, valued at $98.9 million, covering a range of preclinical development support services. Additionally, the company has an IDV with NCI for the PREVENT Cancer Preclinical Drug Development Program, focused on cGMP production of vaccines and biologicals for cancer prevention. These IDVs collectively demonstrate ABL's comprehensive capabilities in supporting the development of vaccines, therapeutics, and diagnostics across multiple disease areas and federal health agencies.
MK4QC9EKZXG8 541714
Not listed 9800 Medical Center Dr, Rockville, MD 20850, USA
10/5/06 2/6/26 Massachusetts Department Of Revenue
The Massachusetts Department of Revenue is a state government entity registered in SAM.gov, primarily functioning as an administrative agency responsible for tax collection and fiscal management for the Commonwealth of Massachusetts. As a child entity within the state government structure, the department has been actively engaged in receiving federal grant awards that focus on social services and family support programs. Through its federal grant portfolio, the department serves as a critical conduit for implementing federal funding initiatives related to child support, family violence prevention, and parental access programs.
The Massachusetts Department of Revenue has consistently received federal grants from the U.S. Department of Health and Human Services, specifically from the Office of Child Support Enforcement and the Administration for Children and Families. Its primary grant activities include the Grants to States for Access and Visitation Programs, which provides approximately $144,475 to $155,002 annually to support initiatives facilitating non-custodial parent engagement through mediation, counseling, and parenting plan development. Additionally, the department manages a substantial $13.7 million block grant for Family Violence Prevention and Services, delivering critical domestic violence shelter and supportive services across Massachusetts. The department strategically sub-awards portions of these grant funds to county governments, non-profit organizations, and community service providers, enabling localized implementation of these important social service programs. The grant awards typically span two to four-year periods, with consistent funding cycles focused on improving family dynamics, child support systems, and preventing domestic violence.
NADGLWMAZDF6 921190
Not listed 100 Cambridge St, Boston, MA 02114, USA
10/30/03 1/14/26